Om DANBIO

Version Info

DANBIO SW-version

Version: 1.0.1

Build nr.: 1.0.1.2026.39.7

Medical Device

Medical Device

DANBIO er et medicinsk udstyr (Medical Device)

UDI

UDI-DI -- Unique Device Identifier

UDI QR code   05700002290908
ZiteLab

ZiteLab ApS

Peter Bangsvej 7A
2000 Frederiksberg

https://zitelab.dk

support@zitelab.dk

Single registration number (SRN): DK-MF-000038975

Help

Brugsanvisning

Se DANBIO online hjælp for yderligere information.

[link til IFU]

CE Mark

CE-mærkning

DANBIO bliver CE-mærket som medicinsk udstyr i klasse IIa, som opfylder kravene i Forordning for medicinsk udstyr (EU) 2017/745, også kaldet MDR.

BSI er notified body for processen, kode: 2797

DANBIO er en applikation på ZiteLabPro platformen.

DANBIO er en database, der består af oplysninger, som anvendes til 3 formål:

  • Behandling: For at følge udviklingen i din gigt og din behandling
  • Forskning: For at gøre behandling af gigt bedre -- nu og i fremtiden
  • Kvalitet: For at sikre høj kvalitet i behandlingen af gigt

DANBIO indsamler PRO-data (patient rapporterede outcomes), når patienter besvarer spørgeskemaer i forbindelse med behandlingen.

About DANBIO

Version Info

DANBIO SW-version

Version: 1.0.1

Build nr.: 1.0.1.2026.39.7

Medical Device

Medical Device

DANBIO is a Medical Device

UDI

UDI-DI -- Unique Device Identifier

UDI QR code   05700002290908
ZiteLab

ZiteLab ApS

Peter Bangsvej 7A
2000 Frederiksberg

https://zitelab.dk

support@zitelab.dk

Single registration number (SRN): DK-MF-000038975

Help

Instruction for use

See DANBIO online help for more information.

[link to IFU]

CE Mark

CE marking

DANBIO will be CE marked as a class IIa medical device, which meets the requirements of the Medical Devices Regulation (EU) 2017/745, also known as MDR.

BSI is notified body of the process, code: 2797

DANBIO is an application on the ZiteLabPro platform

DANBIO is a database consisting of information that is used for 3 purposes:

  • Treatment: To follow the development of your arthritis and your treatment
  • Research: To improve the treatment of arthritis -- now and in the future
  • Quality: To ensure high quality in the treatment of arthritis

DANBIO collects PRO data (patient reported outcomes) when patients answer questionnaires in connection with the treatment.